HAEMOPHILIA B
Clinical trials for HAEMOPHILIA B explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA B trials appear
Sign up with your email to follow new studies for HAEMOPHILIA B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with hemophilia b: experimental drug shows promise in controlling bleeds
Disease control CompletedThis study tested a new medicine (NNC-0156-0000-0009) in 25 children with hemophilia B, a bleeding disorder. The goal was to see if the drug is safe and helps prevent or control bleeding episodes. Children received the drug regularly, and researchers tracked how many bleeds occur…
Matched conditions: HAEMOPHILIA B
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New hope for kids with hemophilia b: Long-Lasting clotting factor shows promise
Disease control CompletedThis study tested a new medicine called nonacog beta pegol (N9-GP) in 54 children under 6 with hemophilia B, a bleeding disorder. The drug is a long-acting clotting factor given regularly to prevent bleeding episodes. The main goal was to see if the children's immune systems woul…
Matched conditions: HAEMOPHILIA B
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for hemophilia b: study tests Long-Acting clotting factor
Disease control CompletedThis study tested a medicine called nonacog beta pegol (N9-GP) in 30 Chinese men with hemophilia B, a bleeding disorder. The medicine helps blood clot and was given as an injection into a vein. The study lasted about 12-16 months and checked how well the medicine stopped bleeding…
Matched conditions: HAEMOPHILIA B
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Japanese hemophilia b patients monitored on refixia in real-world study
Disease control CompletedThis study looked at the safety and effectiveness of Refixia, a medicine for hemophilia B, when used in everyday medical care. It included 28 patients in Japan who were already prescribed Refixia by their doctors. Researchers tracked side effects, bleeding episodes, and quality o…
Matched conditions: HAEMOPHILIA B
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 19, 2026 12:01 UTC